1. Home
  2. Live Updates
  3. Lumos pharma

Live Breaking News & Updates on Lumos pharma

Stay informed with the latest breaking news from Lumos pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lumos pharma and stay connected to the pulse of your community

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings

AUSTIN, Texas, April 18, 2024 -- Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency through Phase 2 clinical trials,...

Stockholm , Sweden , Chicago , Illinois , United-states , Ukraine , Russia , Texas , J-clin-endocrinol , Lisa-miller , Peter-clayton , Lumos-pharma

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings

AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic ca...

Russia , Sweden , Ukraine , Chicago , Illinois , United-states , Stockholm , Texas , Rick-hawkins , Peter-clayton , Lumos-pharma , J-clin-endocrinol

Lumos Pharma (NASDAQ:LUMO) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Lumos Pharma (NASDAQ:LUMO) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Lumos-pharma , Lumos-pharma-inc , Advisor-group , Nasdaq , Envestnet-asset-management-inc , Virtu-financial , Shay-capital , Millennium-management , Get-free-report , Asset-management , Lumos-pharma-daily ,

Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Lumos Pharma ( NASDAQ:LUMO ) Full Year 2023 Results Key Financial Results Net loss: US$34.0m (loss widened by 9.6% from...

Lumos-pharma , Pharma-revenues-beat-expectations ,

AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs

Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make...

Vermont , United-states , California , Axosim-nervesim , Dale-pfost , David-weiner , Merck-serono , Oxford-glycosciences , Lumos-pharma , Lowry-curley , Barbara-lindheim , Santa-barbara

Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024

AUSTIN, Texas, Feb. 26, 2024 -- Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency through Phase 2 clinical trials,...

Texas , United-states , Lisa-miller , Lumos-pharma , Nasdaq , Lumos-pharma-inc , Pediatric-growth-hormone-deficiency , Registration-link , Webcast-link , Orphan-drug-designation , Media-contact , Markets

Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of 49.06% and 2.36%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Lumos-pharma , Zacks-investment-research , While-exact-sciences , Exact-sciences , Zacks-consensus-estimate , Zacks-medical , Zacks-rank , Strong-buy , Zacks-industry-rank , Zacks-investment , Acks-rank , Stimate-revisions

Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Lumos-pharma , How-well-is-lumos-pharma , Ree-cash-flow ,

Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference -February 05, 2024 at 04:06 pm EST

AUSTIN, Texas, Feb. 05, 2024 -- Lumos Pharma, Inc. , a biopharmaceutical company advancing an oral therapeutic candidate for moderate Pediatric Growth Hormone Deficiency , announced today that the...

Texas , United-states , Lumos-pharma , Lisa-miller , Healthcare-life-sciences-conference , Nasdaq , Life-sciences-conference , Lumos-pharma-inc , Pediatric-growth-hormone-deficiency , Annual-healthcare-life-sciences-conference , Annual-life-sciences-conference , Lumos-pharma-investor-relations

Lumos Pharma to Participate in Oppenheimer's 34th Annual Healthcare Life Sciences Conference

AUSTIN, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. LUMO, a biopharmaceutical company advancing an oral therapeutic candidate for moderate…

Texas , United-states , Lumos-pharma , Lumos-pharma-inc , Healthcare-life-sciences-conference , Pediatric-growth-hormone-deficiency , Annual-healthcare-life-sciences-conference , News , Ggregator , Reaking-news , Uration , Edia